Towards Healthcare
Cancer Vaccines Market Size and Top Companies | 11.44% - CAGR Growth

Cancer Vaccines Market Size Envisioned at USD 30.16 Billion by 2033

The report covers Cancer Vaccines Market Companies and Segments Outlook by type, it includes preventive cancer vaccines, therapeutic cancer vaccines and others. By indication, it analyzes vaccines targeting cervical, prostate and other indications. Technologically, it examines recombinant cancer vaccines, viral vector and DNA cancer vaccines, whole-cell cancer vaccines, and others. Distribution channels focusing on hospitals and government suppliers. The report offers the value (in USD Billion) for the above segments.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Cancer Vaccines Market Assessment

  • Overview
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Preventive Cancer Vaccines
    • Therapeutic Cancer Vaccines
    • Others
    • Others
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Cervical Cancer
    • Prostate Cancer
    • Other Indications
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Recombinant Cancer Vaccines
    • Viral Vector and DNA Cancer Vaccines
    • Whole-cell Cancer Vaccines
      Others
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals
    • Government Suppliers
  • Global Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia-Pacific
    • Latin America
    • Middle East & Africa (MEA)

North America Cancer Vaccines Market Assessment

  • Overview
  • Regional trends
  • North America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Preventive Cancer Vaccines
    • Therapeutic Cancer Vaccines
    • Others
  • North America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Cervical Cancer
    • Prostate Cancer
    • Other Indications
  • North America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Recombinant Cancer Vaccines
    • Viral Vector and DNA Cancer Vaccines
    • Whole-cell Cancer Vaccines
    • Others
  • North America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals
    • Government Suppliers

Europe Cancer Vaccines Market Assessment

  • Overview
  • Regional trends
  • Europe Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Preventive Cancer Vaccines
    • Therapeutic Cancer Vaccines
    • Others
  • Europe Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Cervical Cancer
    • Prostate Cancer
    • Other Indications
  • Europe Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Recombinant Cancer Vaccines
    • Viral Vector and DNA Cancer Vaccines
    • Whole-cell Cancer Vaccines
    • Others
  • Europe Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals
    • Government Suppliers

Asia-Pacific Cancer Vaccines Market Assessment

  • Overview
  • Regional trends
  • Asia-Pacific Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Preventive Cancer Vaccines
    • Therapeutic Cancer Vaccines
    • Others
  • Asia-Pacific Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Cervical Cancer
    • Prostate Cancer
    • Other Indications
  • Asia-Pacific Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Recombinant Cancer Vaccines
    • Viral Vector and DNA Cancer Vaccines
    • Whole-cell Cancer Vaccines
    • Others
  • Asia-Pacific Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals
    • Government Suppliers

Latin America Cancer Vaccines Market Assessment

  • Overview
  • Regional trends
  • Latin America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Preventive Cancer Vaccines
    • Therapeutic Cancer Vaccines
    • Others
  • Latin America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Cervical Cancer
    • Prostate Cancer
    • Other Indications
  • Latin America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Recombinant Cancer Vaccines
    • Viral Vector and DNA Cancer Vaccines
    • Whole-cell Cancer Vaccines
    • Others
  • Latin America Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals
    • Government Suppliers

Middle East and Africa Cancer Vaccines Market Assessment

  • Overview
  • Regional trends
  • Middle East and Africa Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Type (2021 – 2033)
    • Preventive Cancer Vaccines
    • Therapeutic Cancer Vaccines
    • Others
  • Middle East and Africa Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Indication (2021 – 2033)
    • Cervical Cancer
    • Prostate Cancer
    • Other Indications
  • Middle East and Africa Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Technology (2021 – 2033)
    • Recombinant Cancer Vaccines
    • Viral Vector and DNA Cancer Vaccines
    • Whole-cell Cancer Vaccines
    • Others
  • Middle East and Africa Cancer Vaccines Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospitals
    • Government Suppliers

Company Profiles

  • Generex Biotechnology Corporation
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • Immunocellular Therapeutics, Ltd
  • Vaccinogen, Inc.
  • GlaxoSmithKline plc (GSK)
  • Advaxis Inc.
  • Dynavax Technologies Corporation
  • Merck & Co., Inc.
  • SANPOWER GROUP CO. LTD. (DENDEREON CORPORATION)
  • UbiVac
  • Amgen Inc.

Conclusion & Recommendations

  • Insight Code: 5153
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: June 2024
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a dedicated market research professional with over 2 years of experience in the healthcare industry. Specializing in healthcare market research, she brings valuable expertise in analyzing market trends, evaluating industry dynamics, and providing actionable insights to help businesses stay ahead in a competitive market.

Throughout her career, Deepa has focused on delivering in-depth research on various healthcare segments, including pharmaceuticals, biotechnology, and healthcare services. She excels in identifying emerging opportunities, assessing market risks, and understanding regulatory changes that impact the healthcare sector.

Her ability to synthesize complex data and translate it into clear, concise recommendations makes her a key contributor to successful strategic decision-making. Her work helps organizations better understand consumer behavior, market demands, and the regulatory landscape, facilitating informed business strategies.

With a passion for healthcare research and a commitment to excellence, Deepa continues to provide businesses with the market intelligence they need to thrive in an increasingly complex healthcare environment. Her insights are critical for companies seeking to navigate the evolving healthcare landscape and optimize their market positioning.

FAQ's

Yes. Vaccines used for treatment are called immunotherapy, treatment vaccines, or therapeutic vaccines. These vaccines prevent the reoccurrence of cancer and the destruction of cancer cells post-treatment, as well as prevent cancer from spreading.

Lung cancer, lymphoma, prostate cancer, ovarian cancer, melanoma, breast cancer, mesothelioma, cervical cancer and reproductive organ cancer.

Research, development, and clinical trials are ongoing to develop combination cancer therapies, oncolytic virus-based vaccines, personalized vaccines, and in situ vaccines or intratumoral therapies.

World Health Organization, National Cancer Institute, National Library of Medicine, Press Information Bureau and Cancer Research Institute.

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 515

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 515